Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10886047 | Drug Discovery Today | 2014 | 10 Pages |
Abstract
Osteoarthritis (OA) is a degenerative joint disease with no curative treatments. Many studies have begun to demonstrate the efficacy of nutraceuticals for slowing down OA. Animal models are utilized as a compulsory step in demonstrating the protective potential of these compounds on joint health. Nevertheless, there exist a wide variety of available OA models and selecting a suitable system for evaluating the effects of a specific compound remains difficult. Here, we discuss animal studies that have investigated nutraceutical effects on OA. In particular, we highlight the large spectrum of animal models that are currently accepted for examining the OA-related effects of nutraceuticals, giving recommendations for their use.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Elsa Mével, Laurent-Emmanuel Monfoulet, Christophe Merceron, Véronique Coxam, Yohann Wittrant, Laurent Beck, Jérôme Guicheux,